scholarly journals Comparison of Prothrombin Time Derived From CoaguChek XS and Laboratory Test According to Fibrinogen Level

2014 ◽  
Vol 29 (1) ◽  
pp. 28-31 ◽  
Author(s):  
Sue Jung Kim ◽  
Eun Young Lee ◽  
Rojin Park ◽  
Juwon Kim ◽  
Jaewoo Song
Keyword(s):  
Laboratory Test ◽  
Prothrombin Time ◽  
Fibrinogen Level ◽  
Coaguchek Xs

Antihemostatic Effect of Hsien-Ho-T'sao (Agrimonia pilosa)

1984 ◽  
Vol 12 (01n04) ◽  
pp. 116-123 ◽  
Author(s):  
Jih-Pyang Wang ◽  
Mei-Feng Hsu ◽  
Che-Ming Teng
Keyword(s):  
Prothrombin Time ◽  
Blood Coagulation ◽  
Partial Thromboplastin Time ◽  
Bleeding Time ◽  
Fibrinogen Level ◽  
Platelet Rich Plasma ◽  
Water Extract ◽  
Activated Partial Thromboplastin Time ◽  
Thrombin Time

Bleeding time in rats was markedly prolonged after the adminstration of the water extract of Hsien-Ho-T'sao. This antihemostatic effect was more marked in the group of i.p. injection of the drug than in the group of p.o. administration for 2 to 7 consecutive days. Blood coagulation studies showed that plasma prothrombin time, activated partial thromboplastin time and stypven time were prolonged, while thrombin time adnd fibrinogen level were not changed. The thromboelastographic recording showed that reation time was prolonged and maximal elasticity of clot was decreased. In addition, ADP- and collagen- induced aggregations of platelet-rich plasma was suppressed. In conclusion, the prolongation of the bleeding time might be due to both anticoagulant and antiplatelet action of the drug.

Comparison of prothrombin time values of standard laboratory test and two point-of-care devices

2008 ◽  
Vol 25 (Sup 44) ◽  
pp. 155
Author(s):  
N. Urwyler ◽  
E. Staub ◽  
L. Staub ◽  
K. Daetwyler ◽  
R. Greif
Keyword(s):  
Laboratory Test ◽  
Prothrombin Time ◽  
Point Of Care ◽  
Standard Laboratory

Utility of CoaguChek XS for Monitoring the Prothrombin Time

2008 ◽  
Vol 65 (6) ◽  
pp. 471 ◽  
Author(s):  
Rojin Park ◽  
Yong-Hyun Kim ◽  
Kyung Ock Kwon ◽  
Jongsung Na ◽  
Yong Soon Won ◽  
...  
Keyword(s):  
Prothrombin Time ◽  
Coaguchek Xs

Assessment of a portable prothrombin time analyzer (CoaguChek-XS) in dogs

2014 ◽  
Vol 24 (4) ◽  
pp. 455-460 ◽  
Author(s):  
Efrat Kelmer ◽  
Gilad Segev ◽  
Carolina Codner ◽  
Yaron Bruchim ◽  
Sigal Klainbart ◽  
...  
Keyword(s):  
Prothrombin Time ◽  
Time Analyzer ◽  
Coaguchek Xs

scholarly journals Estimation of Fibrinogen Level among Sudanese Patients with Myocardial Infraction

2019 ◽  
Vol 9 (6-s) ◽  
pp. 21-27
Author(s):  
Mohammed AL Mustafa Ahmed Edres ◽  
Nihad Elsadig Babiker
Keyword(s):  
Prothrombin Time ◽  
Fibrinogen Level ◽  
Cross Sectional Study ◽  
Control Group ◽  
Case Group ◽  
Cross Sectional ◽  
High Risk Factors ◽  
Myocardial Infraction ◽  
Artery Disease ◽  
And Gender

Myocardial infraction (AMI) is an irreversible myocardial injury and necrosis caused by serious and long-term ischemia. It is generally seen in middle aged men with high risk factors for coronary artery disease. Only 4% of patients with AMI are under 40 years of age. This was a cross sectional study conducted at AL SHAB hospital, Khartoum, Sudan, aimed to estimate the fibrinogen level among Sudanese patients with myocardial infraction. 50 patients attending Alshab Hospital and diagnosed with MI used as a case group and 50 apparently healthy individuals with no history of MI were selected as control group. 1.8 ml of blood samples has been collected in sodium citrate anticoagulant container for measurement of fibrinogen level by clauss method in coagulometer device. It is clearly significant increase in fibrinogen level in myocardial infraction patient (p.value 0.000). In addition, the prothrombin time and gender were insignificantly differences in (AMI) patients. In the other hand, age and smoking significantly increased as risk factor in myocardial infraction. This study concluded that fibrinogen level was significantly increased in Sudanese patients with  myocardial infraction. Keywords: Myochardial Infraction, Fibrinogen, Prothrombin Time, Coagulometer

scholarly journals Assessment of the CoaguChek-XS portable prothrombin time point-of-care analyzer for horses

2019 ◽  
Vol 31 (3) ◽  
pp. 448-452 ◽  
Author(s):  
Noa Berlin ◽  
Efrat Kelmer ◽  
Gilad Segev ◽  
Itamar Aroch ◽  
Gal Kelmer
Keyword(s):  
Prothrombin Time ◽  
High Precision ◽  
Point Of Care ◽  
Reference Interval ◽  
Life Threatening ◽  
The Mean ◽  
Preliminary Study ◽  
Coaguchek Xs ◽  
Roche Diagnostics ◽  
Good Agreement

Coagulopathies in horses are common and potentially life-threatening. In equine field medicine, a portable point-of-care (POC) prothrombin time (PT) testing device could be useful to identify early changes in extrinsic clotting. The CoaguChek-XS (Roche Diagnostics) is a small, portable POC PT analyzer used in human medicine. Our preliminary study assessed the suitability of CoaguChek-XS for testing PT in horses and established the PT reference interval (PT RI) in healthy horses using this instrument. Blood samples collected from 102 healthy and ill horses were analyzed with the CoaguChek-XS and compared to a semi-automated coagulometric analyzer (SACA) as the gold standard. There was a significant positive correlation between the 2 measurement methods ( r = 0.765, p < 0.01), and very good agreement, with 97% of the samples falling within limits of agreement. The mean CoaguChek-XS PT coefficient of variation was 0.8%, indicating high precision. With high precision and good agreement with the coagulometric PT, the CoaguChek-XS should be further validated for PT measurement in horses.

Value of Preoperative Hemostasis Testing in Patients with Liver Disease for Perioperative Hemostatic Management

2017 ◽  
Vol 126 (2) ◽  
pp. 338-344 ◽  
Author(s):  
Ton Lisman ◽  
Robert J. Porte
Keyword(s):  
Platelet Count ◽  
Liver Disease ◽  
Prothrombin Time ◽  
Partial Thromboplastin Time ◽  
Blood Product ◽  
Fibrinogen Level ◽  
Activated Partial Thromboplastin Time

Preoperative hemostasis testing may have limited use in patients with liver disease, and an abnormal platelet count, prothrombin time, activated partial thromboplastin time, and fibrinogen level should not trigger prophylactic transfusion of blood product components.

Sign in / Sign up

Export Citation Format

Share Document